Three types of autoantibodies against the acetylcholine receptors (AChR) of skeletal muscle are detectable in patients with myasthenia gravis including binding, blocking, and modulating anti-AChR antibodies. Modulating autoantibodies correlate best with the severity of the disease, but are also tech
Rhabdomyosarcoma cell line can be used for the isolation of soluble acetylcholine receptor and for assaying blocking and modulating autoantibodies
✍ Scribed by James T. Wu; Mark Astill; Christopher Lloyd; V. C. Salmon
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 742 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0887-8013
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We found that the Rhabdomyosarcoma (RD) cell line expresses human acetylcholine receptor (AChR) based on the following evidences: 1. Soluble AChR can be isolated from RD cells following the isolation procedure for AChR from human muscle; 2. Intact RD cells bind to alpha‐bungarotoxin (αButx) in a time‐dependent and saturable fashion. The apparent dissociation constant (5.3 × 10^−10^ M) is very similar to that reported for TE671 cells, which is known to express AChR; 3. Like fresh muscle culture, RD cells not only bind but also internalize ^125^l‐αButx.
Soluble AChR from RD cells can be labeled specifically with ^125^l‐αButx and then used to quantify binding autoantibodies in myasthenic patients. We also demonstrate that blocking antibodies can be detected in sera from patients with myasthenia gravis (MG) using RD cells and the ability of RD cells to internalize αButx. Consequently, RD cells can be used as a reliable source for obtaining soluble AChR and as a replacement for rodent or human muscle cultures in measuring blocking and modulating antibodies. © 1993 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES